97044610 - VOYAGER

Information

• Trademark
• 97044610

• Source

• Serial Number

  97044610

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 24, 2021
  3 years ago

• Transaction Date

  November 20, 2024
  2 months ago

• Status Date

  November 20, 2024
  2 months ago

• Location Date

  November 20, 2024
  2 months ago

• Status Code

  654

• Current Location

  TMO LAW OFFICE 124 - AWAITING RESPONSE DOCKET

  Employee Name

  HESIK, APRIL

• Attorney Docket Number

  135333-90901

  Attorney Name

  Keith Toms, Esq.

  Law Office Assigned Location Code

  N6C

• Owners

  • Voyager Therapeutics

Case File Statements

• DM0000: The mark consists of the word VOYAGER. The letter "O" is replaced with a design comprising three concentric circles with two circles placed to the upper right and lower left of the concentric circles.
• GS0051: Biological preparations for gene therapy; adeno-associated virus (AAV) gene therapy preparations and pharmaceuticals; Biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; Drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; Drug delivery agents comprising capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics
• GS0441: Medical services provided for clinical trials; Providing patient care for clinical trials; Providing medical and scientific research information in the field of clinical trials and gene therapy; Providing a website featuring medical information and medical research; medical treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies, namely, Parkinson's disease, Huntington's disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, and neurodegenerative disease*
• GS0421: Pharmaceutical research and development in the field of gene therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of RNA-derived functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery

Case File Event Statements

• 9/28/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/26/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/7/2022 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/27/2021 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/10/2022 - 2 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/10/2022 - 2 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/10/2022 - 2 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/10/2022 - 2 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/11/2022 - 2 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/10/2022 - 2 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/14/2022 - 2 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 11/14/2022 - 2 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 11/14/2022 - 2 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 5/19/2023 - a year ago

  14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 7/22/2024 - 6 months ago

  17 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 7/22/2024 - 6 months ago

  18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/26/2024 - 3 months ago

  19 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 11/20/2024 - 2 months ago

  20 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 12/5/2023 - a year ago

  15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 7/22/2024 - 6 months ago

  16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR